Tuesday, December 12, 2017

Neuropsychopharmacology - Table of Contents alert Volume 43 Issue 2

If you are unable to see the message below, click here to view.
Neuropsychopharmacology
TABLE OF CONTENTS

Volume 43, Issue 2 (January 2018)

In this issue
Commentary
Original Articles
Corrigendum
In Memoriam
Retraction

Also new
AOP
 
Follow NPP on Facebook Facebook

Follow NPP on Twitter Twitter

Sign up for e-alerts Sign up for e-alerts
Recommend to your library
Web feed
Subscribe

Commentary

Top

Combinatorial Psycho-Pharmacological Approaches for the Treatment of Abnormal Aggression

Sam A Golden and Aki Takahashi

Neuropsychopharmacology 2018 43: 233-234; advance online publication, October 11, 2017; 10.1038/npp.2017.174

Full Text

Original Articles

Top

Social Learning Requires Plasticity Enhanced by Fluoxetine Through Prefrontal Bdnf-TrkB Signaling to Limit Aggression Induced by Post-Weaning Social Isolation

Éva Mikics, Ramon Guirado, Juzoh Umemori, Máté Tóth, László Biró, Christina Miskolczi, Diána Balázsfi, Dóra Zelena, Eero Castrén, József Haller and Nina N Karpova

Neuropsychopharmacology 2018 43: 235-245; advance online publication, July 7, 2017; 10.1038/npp.2017.142

Abstract | Full Text

Opioid Release after High-Intensity Interval Training in Healthy Human Subjects

Tiina Saanijoki, Lauri Tuominen, Jetro J Tuulari, Lauri Nummenmaa, Eveliina Arponen, Kari Kalliokoski and Jussi Hirvonen

Neuropsychopharmacology 2018 43: 246-254; advance online publication, July 19, 2017; 10.1038/npp.2017.148

Abstract | Full Text

In Vivo Fiber Photometry Reveals Signature of Future Stress Susceptibility in Nucleus Accumbens

Jessie Muir, Zachary S Lorsch, Charu Ramakrishnan, Karl Deisseroth, Eric J Nestler, Erin S Calipari and Rosemary C Bagot

Neuropsychopharmacology 2018 43: 255-263; advance online publication, June 7, 2017; 10.1038/npp.2017.122

Abstract | Full Text

A Longitudinal Study of Violent Behavior in a Psychosis-Risk Cohort

Gary Brucato, Paul S Appelbaum, Jeffrey A Lieberman, Melanie M Wall, Tianshu Feng, Michael D Masucci, Rebecca Altschuler and Ragy R Girgis

Neuropsychopharmacology 2018 43: 264-271; advance online publication, July 26, 2017; 10.1038/npp.2017.151

Abstract | Full Text

Cell-Type-Specific Epigenetic Editing at the Fosb Gene Controls Susceptibility to Social Defeat Stress

Peter J Hamilton, Dominika J Burek, Sonia I Lombroso, Rachael L Neve, Alfred J Robison, Eric J Nestler and Elizabeth A Heller

Neuropsychopharmacology 2018 43: 272-284; advance online publication, May 2, 2017; 10.1038/npp.2017.88

Abstract | Full Text

A Key Role for Neurotensin in Chronic-Stress-Induced Anxiety-Like Behavior in Rats

Catherine P Normandeau, Ana Paula Ventura-Silva, Emily R Hawken, Staci Angelis, Calvin Sjaarda, Xudong Liu, José Miguel Pêgo and É C Dumont

Neuropsychopharmacology 2018 43: 285-293; advance online publication, June 26, 2017; 10.1038/npp.2017.134

Abstract | Full Text

Oxytocin Modulates Attention Switching Between Interoceptive Signals and External Social Cues

Shuxia Yao, Benjamin Becker, Weihua Zhao, Zhiying Zhao, Juan Kou, Xiaole Ma, Yayuan Geng, Peng Ren and Keith M Kendrick

Neuropsychopharmacology 2018 43: 294-301; advance online publication, September 27, 2017; 10.1038/npp.2017.189

Abstract | Full Text

Periaqueductal Gray Glutamatergic Transmission Governs Chronic Stress-Induced Depression

Yu-Cheng Ho, Tzer-Bin Lin, Ming-Chun Hsieh, Cheng-Yuan Lai, Dylan Chou, Yat-Pang Chau, Gin-Den Chen and Hsien-Yu Peng

Neuropsychopharmacology 2018 43: 302-312; advance online publication, August 30, 2017; 10.1038/npp.2017.199

Abstract | Full Text

Dopamine and Stress System Modulation of Sex Differences in Decision Making

Polymnia Georgiou, Panos Zanos, Shambhu Bhat, J Kathleen Tracy, Istvan J Merchenthaler, Margaret M McCarthy and Todd D Gould

Neuropsychopharmacology 2018 43: 313-324; advance online publication, July 25, 2017; 10.1038/npp.2017.161

Abstract | Full Text

Ketamine for Social Anxiety Disorder: A Randomized, Placebo-Controlled Crossover Trial

Jerome H Taylor, Angeli Landeros-Weisenberger, Catherine Coughlin, Jilian Mulqueen, Jessica A Johnson, Daniel Gabriel, Margot O Reed, Ewgeni Jakubovski and Michael H Bloch

Neuropsychopharmacology 2018 43: 325-333; advance online publication, August 29, 2017; 10.1038/npp.2017.194

Abstract | Full Text

Combined Effects of Glucocorticoid and Noradrenergic Activity on Loss Aversion

Zsofia Margittai, Gideon Nave, Marijn Van Wingerden, Alfons Schnitzler, Lars Schwabe and Tobias Kalenscher

Neuropsychopharmacology 2018 43: 334-341; advance online publication, April 14, 2017; 10.1038/npp.2017.75

Abstract | Full Text

Anxiety Associated Increased CpG Methylation in the Promoter of Asb1: A Translational Approach Evidenced by Epidemiological and Clinical Studies and a Murine Model OPEN

Rebecca T Emeny, Jens Baumert, Anthony S Zannas, Sonja Kunze, Simone Wahl, Stella Iurato, Janine Arloth, Angelika Erhardt, Georgia Balsevich, Mathias V Schmidt, Peter Weber, Anja Kretschmer, Liliane Pfeiffer, Johannes Kruse, Konstantin Strauch, Michael Roden, Christian Herder, Wolfgang Koenig, Christian Gieger, Melanie Waldenberger, Annette Peters, Elisabeth B Binder and Karl-Heinz Ladwig

Neuropsychopharmacology 2018 43: 342-353; advance online publication, May 25, 2017; 10.1038/npp.2017.102

Abstract | Full Text

Pharmacological Manipulation of Cortical Inhibition in the Dorsolateral Prefrontal Cortex

Bahar Salavati, Tarek K Rajji, Reza Zomorrodi, Daniel M Blumberger, Robert Chen, Bruce G Pollock and Zafiris J Daskalakis

Neuropsychopharmacology 2018 43: 354-361; advance online publication, May 29, 2017; 10.1038/npp.2017.104

Abstract | Full Text

κ-Opioid Receptor Activation in Dopamine Neurons Disrupts Behavioral Inhibition

Antony D Abraham, Harrison M Fontaine, Allisa J Song, Mackenzie M Andrews, Madison A Baird, Brigitte L Kieffer, Benjamin B Land and Charles Chavkin

Neuropsychopharmacology 2018 43: 362-372; advance online publication, June 26, 2017; 10.1038/npp.2017.133

Abstract | Full Text

Memory Retention Involves the Ventrolateral Orbitofrontal Cortex: Comparison with the Basolateral Amygdala

Kelsey S Zimmermann, Chen-chen Li, Donald G Rainnie, Kerry J Ressler and Shanmon L Gourley

Neuropsychopharmacology 2018 43: 373-383; advance online publication, June 30, 2017; 10.1038/npp.2017.139

Abstract | Full Text

Neural Underpinnings of Cortisol Effects on Fear Extinction

Christian Josef Merz, Tanja Christina Hamacher-Dang, Rudolf Stark, Oliver Tobias Wolf and Andrea Hermann

Neuropsychopharmacology 2018 43: 384-392; advance online publication, September 26, 2017; 10.1038/npp.2017.227

Abstract | Full Text

Failure to Inactivate Nuclear GSK3β by Ser389-Phosphorylation Leads to Focal Neuronal Death and Prolonged Fear Response

Tina M Thornton, Brendan Hare, Sandra Colié, William W Pendlebury, Angel R Nebreda, William Falls, Diane M Jaworski and Mercedes Rincon

Neuropsychopharmacology 2018 43: 393-405; advance online publication, August 17, 2017; 10.1038/npp.2017.187

Abstract | Full Text

The 5-HTTLPR Polymorphism Affects Network-Based Functional Connectivity in the Visual-Limbic System in Healthy Adults

Hengyi Cao, Anais Harneit, Henrik Walter, Susanne Erk, Urs Braun, Carolin Moessnang, Lena S Geiger, Zhenxiang Zang, Sebastian Mohnke, Andreas Heinz, Nina Romanczuk-Seiferth, Thomas Mühleisen, Manuel Mattheisen, Stephanie H Witt, Sven Cichon, Markus M Nöthen, Marcella Rietschel, Andreas Meyer-Lindenberg and Heike Tost

Neuropsychopharmacology 2018 43: 406-414; advance online publication, June 7, 2017; 10.1038/npp.2017.121

Abstract | Full Text

Activation of the GABAergic Parafacial Zone Maintains Sleep and Counteracts the Wake-Promoting Action of the Psychostimulants Armodafinil and Caffeine

Christelle Anaclet, Kobi Griffith and Patrick M Fuller

Neuropsychopharmacology 2018 43: 415-425; advance online publication, July 19, 2017; 10.1038/npp.2017.152

Abstract | Full Text

The Insular Cortex Dynamically Maps Changes in Cardiorespiratory Interoception OPEN

Mahlega S Hassanpour, W Kyle Simmons, Justin S Feinstein, Qingfei Luo, Rachel C Lapidus, Jerzy Bodurka, Martin P Paulus and Sahib S Khalsa

Neuropsychopharmacology 2018 43: 426-434; advance online publication, August 9, 2017; 10.1038/npp.2017.154

Abstract | Full Text

Antimanic Efficacy of a Novel Kv3 Potassium Channel Modulator

Puja K Parekh, Michelle M Sidor, Andrea Gillman, Darius Becker-Krail, Letizia Bettelini, Roberto Arban, Giuseppe S Alvaro, Erika Zambello, Chiara Mutinelli, Yanhua Huang, Charles H Large and Colleen A McClung

Neuropsychopharmacology 2018 43: 435-444; advance online publication, August 31, 2017; 10.1038/npp.2017.155

Abstract | Full Text

Telomere Length and Bipolar Disorder

Timothy R Powell, Danai Dima, Sophia Frangou and Gerome Breen

Neuropsychopharmacology 2018 43: 445-453; advance online publication, June 16, 2017; 10.1038/npp.2017.125

Abstract | Full Text

Corrigendum

Top

Telomere Length and Bipolar Disorder OPEN

Timothy R Powell, Danai Dima, Sophia Frangou and Gerome Breen

Neuropsychopharmacology 2018 43: 454; 10.1038/npp.2017.239

Full Text

In Memoriam

Top

Carmen Keith Conners

Bernard J Carroll

Neuropsychopharmacology 2018 43: 455; 10.1038/npp.2017.240

Full Text

Retraction

Top

Decrease in the AP-2 DNA-Binding Activity and in the Protein Expression of AP-2 a and AP-2 b in Frontal Cortex of Rats Treated with Lithium for 6 Weeks

Jagadeesh S Rao, Stanley I Rapoport and Francesca Bosetti

Neuropsychopharmacology 2018 43: 456; 10.1038/npp.2017.237

Full Text

Please note that you need to be a subscriber or site-license holder to enjoy full-text access to Neuropsychopharmacology. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Springer Nature's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.

© 2017 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.

Springer Nature
 

No comments: